Table 1.
Correlation between Anillin transcript and clinicopathologic features in 87 HCC specimens.
Anillin transcript level associated with clinicopathologic features in 87 HCC patients, including age, gender, tumor size, tumor stage (AJCC), tumor encapsulation, tumor microsatellite formation, vein invasion, HBsAg status, AFP level, and liver cirrhosis. Statistically significance was assessed by Fish's exact text.
| Clinicopathologic parameters | Anillin expression |
P* | |
|---|---|---|---|
| Low (n = 28) | High (n = 59) | ||
| Age (years) | |||
| ≤50 | 13 | 33 | 0.492 |
| >50 | 15 | 26 | |
| Gender | |||
| Male | 18 | 28 | 0.172 |
| Female | 10 | 31 | |
| Diameter (cm) | |||
| ≤5 | 19 | 24 | 0.0225 |
| >5 | 9 | 35 | |
| TNM stage | |||
| I–II | 16 | 16 | 0.0164 |
| III–IV | 12 | 41 | |
| Tumor encapsulation | |||
| Absent | 15 | 21 | 0.162 |
| Present | 13 | 38 | |
| Tumor microsatellite formation | |||
| Absent | 16 | 21 | 0.067 |
| Present | 12 | 38 | |
| Venous invasion | |||
| No | 14 | 14 | 0.026 |
| Yes | 14 | 45 | |
| HBsAg | |||
| Negative | 4 | 7 | 0.741 |
| Positve | 24 | 52 | |
| AFP (ng/ml) | |||
| ≤400 | 9 | 11 | 0.181 |
| >400 | 19 | 48 | |
| Cirrhosis | |||
| Absent | 7 | 3 | 0.011 |
| Present | 21 | 56 | |